Net Cash Provided by (Used in) Financing Activities in USD of Iterum Therapeutics plc from 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Iterum Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to Q1 2025.
  • Iterum Therapeutics plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$8.39M, a 216% decline year-over-year.
  • Iterum Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $26.7M, a 2481% increase from 2023.
  • Iterum Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.03M.
  • Iterum Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.82M, a 102% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Iterum Therapeutics plc Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$8.39M -$15.6M -216% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q1 2024 $7.22M +$6.98M +2971% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q1 2023 $235K +$2.49M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 -$2.25M -$89.2M -103% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $87M +$41.1M +89.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $45.9M +$45.8M +93514% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $49K -$32.1M -99.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $32.2M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14

Iterum Therapeutics plc Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $26.7M +$25.7M +2481% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-07
2023 $1.03M +$2.85M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-07
2022 -$1.82M -$84.9M -102% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-07
2021 $83.1M +$18.7M +28.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 $64.5M +$62.4M +3025% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $2.06M -$120M -98.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-28
2018 $122M +$76.3M +166% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $45.9M +$25M +120% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $20.9M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.